NCT06270810

Brief Summary

The goal of this clinical trial is to investigate whether increasing non-exercise physical activity combined with aerobic exercise in overweight young women is superior to performing aerobic exercise alone in terms of some cardiometabolic variables. The main question it aims to answer is: • Do both increasing non-exercise physical activity and doing aerobic exercise add more beneficial cardiometabolic effects to performing aerobic exercise alone in overweight young women? To answer this question, overweight young women will be randomly assigned to two different groups of this research. Volunteers in one of the groups will do moderate-intensity aerobic training and the other group will increase their non-exercise physical activities in addition to moderate-intensity aerobic training. Then researchers will compare two groups to see the differences in cardiometabolic variables.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2024

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 14, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

February 21, 2024

Completed
19 days until next milestone

Study Start

First participant enrolled

March 11, 2024

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 18, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2025

Completed
Last Updated

January 6, 2026

Status Verified

December 1, 2025

Enrollment Period

1.3 years

First QC Date

February 14, 2024

Last Update Submit

December 31, 2025

Conditions

Keywords

Overweightnon-Exercise Physical ActivityAerobic ExerciseSedentary BehaviourPhysical ActivityStep CountsCardiometabolicBlood LipidsSerum GlucoseHbA1cBlood PressureYoung WomenCardiorespiratory Fitness

Outcome Measures

Primary Outcomes (8)

  • Low Density Lipoprotein (LDL) Cholesterol

    Fasting blood samples will be taken by applying a vacutainer needle to the appropriate vein following a 12-hour fast and will be analyzed immediately in the biochemistry laboratory.

    The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions

  • High Density Lipoprotein (HDL) Cholesterol

    Fasting blood samples will be taken by applying a vacutainer needle to the appropriate vein following a 12-hour fast and will be analyzed immediately in the biochemistry laboratory.

    The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions

  • Total Cholesterol

    Fasting blood samples will be taken by applying a vacutainer needle to the appropriate vein following a 12-hour fast and will be analyzed immediately in the biochemistry laboratory.

    The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions

  • Glycated Hemoglobin (HbA1C)

    Fasting blood samples will be taken by applying a vacutainer needle to the appropriate vein following a 12-hour fast and will be analyzed immediately in the biochemistry laboratory.

    The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions

  • Serum Triglycerides

    Fasting blood samples will be taken by applying a vacutainer needle to the appropriate vein following a 12-hour fast and will be analyzed immediately in the biochemistry laboratory.

    The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions

  • Maximal Oxygen Consumption

    Maximal oxygen consumption will be estimated by the Rockport 1 Mile Walk Test

    The week before the beginning of the interventions, and the week after the interventions

  • Systolic Blood Pressure

    Measurements will be made on the arm with a digital blood pressure monitor after resting for at least 10 minutes in a supine position to ensure hemodynamic stability. By wrapping the cuff around the arm, brachial systolic blood pressure will be automatically measured.

    The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions

  • Diastolic Blood Pressure

    Measurements will be made on the arm with a digital blood pressure monitor after resting for at least 10 minutes in a supine position to ensure hemodynamic stability. By wrapping the cuff around the arm, brachial diastolic blood pressure will be automatically measured.

    The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions

Secondary Outcomes (4)

  • Body Fat Percentage

    The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions

  • Fat-free Mass

    The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions

  • Waist Circumference

    The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions

  • Hip Circumference

    The week before the beginning of the interventions, at 4th week of the intervention , and the week after the interventions

Study Arms (2)

Aerobic Exercise (AeroEx) Group

EXPERIMENTAL

Participants in this group will do moderate-intensity aerobic training for 4 days a week for 8 weeks.

Behavioral: Aerobic Exercise

Aerobic Exercise+non-Exercise (nE) Physical Activity (AeroEx+nE PA) Group

EXPERIMENTAL

Participants in this group will increase their non-exercise physical activities and do moderate-intensity aerobic training for four days a week for 8 weeks.

Behavioral: Aerobic ExerciseBehavioral: Increasing non-Exercise Physical Activity

Interventions

Aerobic exercise will be performed on the treadmill at 40-60% of the participants' heart rate reserves. Each aerobic exercise session will last for 40 minutes. All participants will be monitored with a heart rate monitor throughout the exercise sessions. During the first three-week, participants will exercise on the treadmill at intensities between 40-50%, and between fourth and eighth weeks, 50-60% of their heart rate reserves. Participants will wear an accelerometer on their non-dominant wrist during the intervention to monitor the physical activity and sedentary behavior data. At the same time, these participants will be asked not to change their routine diet during the intervention period.

Aerobic Exercise (AeroEx) GroupAerobic Exercise+non-Exercise (nE) Physical Activity (AeroEx+nE PA) Group

Participants who will carry out this intervention will increase their non-exercise physical activities. Before intervention period, participants will receive face-to-face training to increase their non-exercise physical activities. This training will generally consist of recommendations based on the study which effectively reduced sedentary behavior (SB) with non-exercise physical activities (Sarah Kozey-Keadle et al. 2012). A one-on-one interview will be held with each participant every week to learn about strategies by which the volunteers successfully increased their non-exercise physical activities in the previous week, and the difficulties or barriers they encountered. New strategies to overcome these difficulties and barriers will be discussed and suggestions will be made. Participants will wear an accelerometer on their non-dominant wrist to monitor the physical activity and SB data, and will be asked not to change their routine diet during the intervention period.

Aerobic Exercise+non-Exercise (nE) Physical Activity (AeroEx+nE PA) Group

Eligibility Criteria

Age18 Years - 35 Years
Sexfemale(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • To have a body mass index between 25 kg.(m2)-1 and 29.9 kg.(m2)-1
  • Self reported sitting time greater than 7 hours per day
  • Not exercising regularly in the last 3 months

You may not qualify if:

  • Hypertension
  • Coronary heart disease
  • Heart failure
  • Diabetes mellitus (A1C being 6.5% and above)
  • Prediabetes (A1C between 5.7% and 6.4%)
  • Metabolic syndrome
  • Hypothyroidism
  • Non-alcoholic fatty liver disease
  • Chronic inflammatory disease
  • Chronic renal failure
  • Cushing's syndrome
  • Musculoskeletal disorder that will affect the ability to do physical activity
  • HIV infection
  • Being on antihypertensive medication
  • Being on lipid-lowering medication
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kastamonu University, Çatalzeytin Vocational School

Çatalzeytin, Kastamonu, 37, Turkey (Türkiye)

Location

Related Publications (2)

  • Kozey-Keadle S, Libertine A, Staudenmayer J, Freedson P. The Feasibility of Reducing and Measuring Sedentary Time among Overweight, Non-Exercising Office Workers. J Obes. 2012;2012:282303. doi: 10.1155/2012/282303. Epub 2011 Nov 16.

    PMID: 22175004BACKGROUND
  • Kozey Keadle S, Lyden K, Staudenmayer J, Hickey A, Viskochil R, Braun B, Freedson PS. The independent and combined effects of exercise training and reducing sedentary behavior on cardiometabolic risk factors. Appl Physiol Nutr Metab. 2014 Jul;39(7):770-80. doi: 10.1139/apnm-2013-0379. Epub 2014 Jan 7.

    PMID: 24971677BACKGROUND

MeSH Terms

Conditions

OverweightMotor Activity

Interventions

Exercise

Condition Hierarchy (Ancestors)

OvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

February 14, 2024

First Posted

February 21, 2024

Study Start

March 11, 2024

Primary Completion

June 18, 2025

Study Completion

September 1, 2025

Last Updated

January 6, 2026

Record last verified: 2025-12

Locations